{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:29:25Z","timestamp":1791307765520,"version":"4.3.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,6,20]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Blockade of VWF-A1 by ALX-0081 induces reperfusion of a thrombus-occluded middle cerebral artery without provoking cerebral bleeding. The interaction between GPIb and VWF is not only essential for platelet adhesion but also for initial thrombus stabilization.<\/jats:p>","DOI":"10.1182\/blood-2012-11-464545","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T23:00:55Z","timestamp":1366066855000},"page":"5088-5097","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["Reperfusion of cerebral artery thrombosis by the GPIb\u2013VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs"],"prefix":"10.1182","volume":"121","author":[{"given":"Stefania","family":"Momi","sequence":"first","affiliation":[{"name":"Section of Internal and Cardiovascular Medicine, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tantucci","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Van Roy","sequence":"additional","affiliation":[{"name":"Ablynx, Zwijnaarde, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Ulrichts","sequence":"additional","affiliation":[{"name":"Ablynx, Zwijnaarde, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ricci","sequence":"additional","affiliation":[{"name":"Histology Section, Animal Facility, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gresele","sequence":"additional","affiliation":[{"name":"Section of Internal and Cardiovascular Medicine, Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111802544977200_B1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"issue":"3","key":"2019111802544977200_B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10739680590925484","article-title":"Interactions of platelets with subendothelium and endothelium.","volume":"12","author":"Chen","year":"2005","journal-title":"Microcirculation"},{"issue":"1","key":"2019111802544977200_B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrd985","article-title":"Scientific and therapeutic advances in antiplatelet therapy.","volume":"2","author":"Bhatt","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2019111802544977200_B4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.ATV.0000066686.46338.F1","article-title":"Integrin \u03b1IIb\u03b23 and its antagonism.","volume":"23","author":"Quinn","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019111802544977200_B5","article-title":"Antiplatelet agents in clinical practice and their haemorragic risk.","author":"Gresele","year":"2013","journal-title":"Blood Transfus-Italy"},{"issue":"4","key":"2019111802544977200_B6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1538-7836.2010.03737.x","article-title":"Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding.","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2019111802544977200_B7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/CIRCULATIONAHA.106.653741","article-title":"Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?","volume":"115","author":"Liao","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"2019111802544977200_B8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/STROKEAHA.107.497271","article-title":"Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review.","volume":"39","author":"O\u2019Donnell","year":"2008","journal-title":"Stroke"},{"issue":"1","key":"2019111802544977200_B9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-6147(00)01885-X","article-title":"Novel approaches to the treatment of thrombosis.","volume":"23","author":"Gresele","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"2019111802544977200_B10","first-page":"CD000029","article-title":"Antiplatelet therapy for acute ischaemic stroke.","author":"Sandercock","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"2019111802544977200_B11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes.","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"2019111802544977200_B12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/STROKEAHA.106.476648","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"issue":"8","key":"2019111802544977200_B13","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.STR.0000080535.61188.A6","article-title":"Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.","volume":"34","author":"Seitz","year":"2003","journal-title":"Stroke"},{"issue":"5","key":"2019111802544977200_B14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","article-title":"Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"2019111802544977200_B15","first-page":"CD000213","article-title":"Thrombolysis for acute ischaemic stroke.","author":"Wardlaw","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"2019111802544977200_B16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke.","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111802544977200_B17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2796.2009.02205.x","article-title":"The molecular basis of thrombolysis and its clinical application in stroke.","volume":"267","author":"Murray","year":"2010","journal-title":"J Intern Med"},{"issue":"5","key":"2019111802544977200_B18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2011.04243.x","article-title":"Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review.","volume":"9","author":"van Schie","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111802544977200_B19","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/STROKEAHA.110.586289","article-title":"High von Willebrand factor levels increase the risk of stroke: the Rotterdam study.","volume":"41","author":"Wieberdink","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"2019111802544977200_B20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2010.04134.x","article-title":"Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke.","volume":"9","author":"Hanson","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2019111802544977200_B21","author":"Gresele"},{"issue":"3","key":"2019111802544977200_B22","first-page":"527","article-title":"ADAMTS13 exerts a thrombolytic effect in microcirculation.","volume":"108","author":"Crescente","year":"2012","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111802544977200_B23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood-2010-11-317859","article-title":"Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs.","volume":"118","author":"Ulrichts","year":"2011","journal-title":"Blood"},{"issue":"17","key":"2019111802544977200_B24","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2012-04-420943","article-title":"Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura.","volume":"120","author":"Callewaert","year":"2012","journal-title":"Blood"},{"issue":"12","key":"2019111802544977200_B25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3324\/haematol.11313","article-title":"Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand\u2019s disease by flow cytometry.","volume":"92","author":"Giannini","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"2019111802544977200_B26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cyto.b.20396","article-title":"A new case of acquired Glanzmann\u2019s thrombasthenia: diagnostic value of flow cytometry.","volume":"74","author":"Giannini","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"issue":"11","key":"2019111802544977200_B27","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1084\/jem.20090687","article-title":"Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo.","volume":"206","author":"Momi","year":"2009","journal-title":"J Exp Med"},{"issue":"1","key":"2019111802544977200_B28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjp.0701354","article-title":"Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.","volume":"122","author":"Kageyama","year":"1997","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2019111802544977200_B29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH04-07-0464","article-title":"Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice.","volume":"93","author":"Momi","year":"2005","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111802544977200_B30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/jappl.1950.3.6.365","article-title":"Morphology and enumeration of human blood platelets.","volume":"3","author":"Brecher","year":"1950","journal-title":"J Appl Physiol"},{"issue":"11","key":"2019111802544977200_B31","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/j.1538-7836.2005.01605.x","article-title":"A novel nitric oxide-releasing statin derivative exerts an antiplatelet\/antithrombotic activity and inhibits tissue factor expression.","volume":"3","author":"Rossiello","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111802544977200_B32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0008-6363(02)00657-0","article-title":"Endothelin-1 induced proinflammatory markers in the myocardium and leukocytes of guinea-pigs: role of glycoprotein IIB\/IIIA receptors.","volume":"57","author":"Molero","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"11","key":"2019111802544977200_B33","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1089\/neu.2005.22.1362","article-title":"Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb\/IIIa antagonist.","volume":"22","author":"Mihara","year":"2005","journal-title":"J Neurotrauma"},{"issue":"2","key":"2019111802544977200_B34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.23762","article-title":"Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.","volume":"73","author":"Wang","year":"2013","journal-title":"Ann Neurol"},{"issue":"3","key":"2019111802544977200_B35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI575","article-title":"Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.","volume":"101","author":"Gresele","year":"1998","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111802544977200_B36","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.STR.28.11.2296","article-title":"Use of a spectrophotometric haemoglobin assay to objectively quantify intracerebral hemorrhage in mice.","volume":"28","author":"Choudhri","year":"1997","journal-title":"Stroke"},{"issue":"2","key":"2019111802544977200_B37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/STROKEAHA.111.628867","article-title":"von Willebrand factor: an emerging target in stroke therapy.","volume":"43","author":"De Meyer","year":"2012","journal-title":"Stroke"},{"issue":"10","key":"2019111802544977200_B38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/ATVBAHA.110.208918","article-title":"Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb\/IIIa, contributes to ischemic stroke in mice\u2014brief report.","volume":"30","author":"De Meyer","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2019111802544977200_B39","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI7569","article-title":"A revised model of platelet aggregation.","volume":"105","author":"Kulkarni","year":"2000","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"2019111802544977200_B40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1538-7836.2009.03401.x","article-title":"Dynamics of platelet thrombus formation.","volume":"7","author":"Jackson","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111802544977200_B41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1160\/TH11-10-0705","article-title":"The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.","volume":"107","author":"Boulaftali","year":"2012","journal-title":"Thromb Haemost"},{"issue":"8","key":"2019111802544977200_B42","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2009-06-230110","article-title":"ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.","volume":"115","author":"Fujioka","year":"2010","journal-title":"Blood"},{"issue":"15","key":"2019111802544977200_B43","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood-2009-03-213264","article-title":"von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.","volume":"114","author":"Zhao","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111802544977200_B44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.WCB.0000078322.96027.78","article-title":"Cerebral microvessel responses to focal ischemia.","volume":"23","author":"del Zoppo","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"2019111802544977200_B45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2170\/jjphysiol.47.431","article-title":"The differential involvement of von Willebrand factor, fibrinogen and fibronectin in acute experimental thrombosis in rat cerebral and mesenteric microvessels.","volume":"47","author":"Yamamoto","year":"1997","journal-title":"Jpn J Physiol"},{"issue":"12","key":"2019111802544977200_B46","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1586\/erc.10.154","article-title":"Targeting von Willebrand factor and platelet glycoprotein Ib receptor.","volume":"8","author":"Firbas","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"17","key":"2019111802544977200_B47","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","article-title":"Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb\/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.","volume":"115","author":"Kleinschnitz","year":"2007","journal-title":"Circulation"},{"issue":"12","key":"2019111802544977200_B48","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V77.12.2547.2547","article-title":"The bleeding time does not predict surgical bleeding.","volume":"77","author":"Lind","year":"1991","journal-title":"Blood"},{"issue":"1","key":"2019111802544977200_B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1002658","article-title":"A critical reappraisal of the bleeding time.","volume":"16","author":"Rodgers","year":"1990","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/25\/5088\/1366745\/5088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/25\/5088\/1366745\/5088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T02:56:53Z","timestamp":1574045813000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/25\/5088\/125565\/Reperfusion-of-cerebral-artery-thrombosis-by-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":49,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2013,6,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-11-464545","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718025930.793479672","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]}}}